COVID-19: India's first mRNA Covid vaccine candidate gets nod to start phase 2, 3 trials

The Indian drugs regulator, the Drugs Controller General of India (DCGI) on Tuesday has granted approval for Phase 2 and 3 clinical trials of India's first mRNA Covid-19 vaccine candidate — HGCO19 — that is being developed by Gennova Biopharmaceuticals.

Leave a Reply

Your email address will not be published. Required fields are marked *

COVID-19: India's first mRNA Covid vaccine candidate gets nod to start phase 2, 3 trials

The Indian drugs regulator, the Drugs Controller General of India (DCGI) on Tuesday has granted approval for Phase 2 and 3 clinical trials of India's first mRNA Covid-19 vaccine candidate — HGCO19 — that is being developed by Gennova Biopharmaceuticals.

Leave a Reply

Your email address will not be published. Required fields are marked *